Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

DRX-Evolution Plus System

K-Number: K233381 · 2024-03-12

Decision Date2024-03-12
Product CodeKPR
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

DRX-Evolution Plus System is a medical device manufactured by Carestream Health, Inc.. It received FDA 510(k) clearance on 2024-03-12 under approval number K233381. The device is classified under product code KPR. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the DRX-Evolution Plus System?

DRX-Evolution Plus System is a medical device that received FDA 510(k) clearance on 2024-03-12. It is manufactured by Carestream Health, Inc.. The 510(k) number is K233381.

When was DRX-Evolution Plus System approved by the FDA?

DRX-Evolution Plus System received FDA 510(k) clearance on 2024-03-12, under approval number K233381.

What company makes DRX-Evolution Plus System?

DRX-Evolution Plus System is manufactured by Carestream Health, Inc..

What is the FDA product code for DRX-Evolution Plus System?

The FDA product code for DRX-Evolution Plus System is KPR.

Related Clinical Trials

Related PubMed Literature

Other Devices by Carestream Health, Inc.

View all 23 devices →

Related Devices (Code: KPR)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.